Patents by Inventor Philip A. WATSON

Philip A. WATSON has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Combination therapies for treatment of cancer
    Patent number: 10933134
    Abstract: A method for treatment of prostate cancer or benign prostate hyperplasia by combination therapy comprising administering to a patient an androgen-deprivation therapy agent and a bacteriochlorophyll derivative followed by photodynamic therapy (PDT) or vascular-targeted photodynamic therapy (VTP).
    Type: Grant
    Filed: March 16, 2018
    Date of Patent: March 2, 2021
    Assignees: Memorial Sloan Kettering Cancer Center, Yeda Research and Development Co. Ltd., at the Weizmann Institute of Science
    Inventors: Jonathan Coleman, Philip A. Watson, Kwanghee Kim, Avigdor Scherz
  • COMBINATION THERAPIES FOR TREATMENT OF CANCER
    Publication number: 20180296675
    Abstract: A method for treatment of prostate cancer or benign prostate hyperplasia by combination therapy comprising administering to a patient an androgen-deprivation therapy agent and a bacteriochlorophyll derivative followed by photodynamic therapy (PDT) or vascular-targeted photodynamic therapy (VTP).
    Type: Application
    Filed: March 16, 2018
    Publication date: October 18, 2018
    Inventors: Jonathan COLEMAN, Philip A. WATSON, Kwanghee KIM, Avigdor SCHERZ